Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur J Gastroenterol Hepatol ; 8(7): 651-5, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8853253

RESUMEN

OBJECTIVE: To assess whether psychological factors distinguished patients with Crohn's disease (CD) from those with ulcerative colitis (UC). DESIGN: Survey of prevalent inflammatory bowel disease patients (n = 82) attending a gastroenterology clinic. METHODS: Administration of three self-report rating scales, the Eysenck Personality Questionnaire, the General Health Questionnaire and the Hospital Anxiety and Depression scale. RESULTS: CD patients were significantly more extroverted (P = 0.04) than UC patients, tended to have higher psychoticism scores (P = 0.06) but similar neuroticism scores. Extroversion and psychoticism scores were weakly associated with smoking status. In logistic regression models that adjusted for age, sex and smoking the associations with extroversion and psychoticism scores persisted but were no longer significant at the 5% level. In the final model the psychoticism score was more important than the extroversion score. CONCLUSION: These results suggest that there are substantial personality differences between patients with CD and UC. Although some of the differences in this study were associated with smoking, adjusting for smoking reduced, but did not abolish, the associations with personality scores.


Asunto(s)
Colitis Ulcerosa/psicología , Enfermedad de Crohn/psicología , Personalidad , Fumar/epidemiología , Colitis Ulcerosa/epidemiología , Enfermedad de Crohn/epidemiología , Femenino , Estado de Salud , Encuestas Epidemiológicas , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Inventario de Personalidad , Fumar/psicología , Encuestas y Cuestionarios
2.
Am J Hematol ; 46(4): 325-8, 1994 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8037184

RESUMEN

Life-threatening portal hypertension (PHN) in patients with chronic myeloproliferative disorders may result from increased portal flow caused by marked splenomegaly or an increased resistance to portal flow from either a large vein thrombosis or an intrahepatic obstruction usually associated with agnogenic myeloid metaplasia (AMM). The former cause is correctable by splenectomy alone, whereas the latter requires portal-systemic shunt surgery. Few data exist regarding the outcome of portal-systemic shunt surgery in patients with AMM and intrahepatic obstruction. During the past 25 years, 13 patients with chronic myeloproliferative disorders underwent portal-systemic shunt surgery at our institution. The cause of PHN was intrahepatic obstruction in ten patients and hepatic vein thrombosis in three. Ten of the thirteen patients had AMM as initial diagnosis. Only one patient had intraoperative complications, and four patients had either sepsis or thrombosis during the postoperative period. Twelve patients survived the postoperative period and had a median postsurgical survival of 3 years (range, 0.25 to 19 years). The long-term complications of the operation were very few and included hepatic encephalopathy (one patient), portal vein thrombosis (one patient), and shunt occlusion (one patient). The procedure was successful in alleviating complications of PHN in all but one patient. Deterioration of hepatic function and subsequent hepatomegaly were unusual. Portal-systemic shunt surgery seems to be a useful option in patients with AMM and life-threatening PHN from intrahepatic obstruction.


Asunto(s)
Colestasis Intrahepática/complicaciones , Hipertensión Portal/etiología , Hipertensión Portal/cirugía , Derivación Portosistémica Quirúrgica , Mielofibrosis Primaria/complicaciones , Adulto , Anciano , Femenino , Humanos , Hipertensión Portal/mortalidad , Masculino , Persona de Mediana Edad , Análisis de Supervivencia , Resultado del Tratamiento
3.
Ann Emerg Med ; 24(1): 21-5, 1994 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8010544

RESUMEN

STUDY OBJECTIVES: We tested the null hypothesis that no outcome differences exist among the treatment groups of animals with brown recluse spider envenomations. STUDY DESIGN: A prospective, placebo-controlled, experimental trial. Hartley guinea pigs were randomized into the following treatment groups: dapsone, Parali/azer stun gun, Guardian stun gun, and control. INTERVENTIONS: Brown recluse spider skin lesions were induced with intradermal injections of 30 micrograms spider venom and were treated beginning 16 hours after inoculation. Shock regimens consisted of four cross shocks of 1-second duration on anesthetized animals. Oral dapsone treatment was 0.7 mg/kg twice daily for 3 days. Lesion areas were measured daily for 3 days. RESULTS: The dapsone therapy group demonstrated significantly less induration and necrosis (P < .05) than that shown by the other three groups 72 hours after envenomation. CONCLUSION: Dapsone therapy is more effective than either electric shock or no therapy for brown recluse spider envenomation in the guinea pig model.


Asunto(s)
Dapsona/uso terapéutico , Terapia por Estimulación Eléctrica , Picaduras de Arañas/terapia , Análisis de Varianza , Animales , Terapia por Estimulación Eléctrica/instrumentación , Diseño de Equipo , Cobayas , Estudios Prospectivos , Distribución Aleatoria , Picaduras de Arañas/tratamiento farmacológico
4.
Am J Emerg Med ; 12(1): 36-42, 1994 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8285969

RESUMEN

The objective of this study was to test the hypothesis that after hemorrhagic hypotension, reinfusion of the shed blood with threefold that volume of lactated Ringer's (LR) solution will significantly increase lung water and venous admixture and hence decrease systemic arterial oxygen saturation. A prospective, randomized, fixed-volume hemorrhage laboratory study was performed at the Oklahoma University Health Sciences Center on 18 anesthetized mongrel dogs. After 40 mL/kg of blood were withdrawn through a femoral artery catheter, the dogs were randomized either to the control group (n = 9) that received a reinfusion of the shed blood, or to the LR treatment group (n = 9) that received an intravenous mixture of the shed blood with 120 mL/kg of LR. After fluid resuscitation, pulmonary artery occlusion pressure (PAOP) and cardiac output (CO) were significantly increased in the LR group compared with control animals (PAOP, 18.7 +/- 1.1 vs 13.4 +/- 2.9 mm Hg; CO, 8.14 +/- 1.08 vs 4.59 +/- 0.47 L/min; P < .05 each). However, lung water, venous admixture, and systemic arterial PO2 were similar between groups. In this fixed-volume hemorrhage model, hemodiluting the reinfused shed blood with threefold the volume of LR did not significantly influence lung water, venous admixture, or systemic arterial oxygen saturation.


Asunto(s)
Agua Pulmonar Extravascular/efectos de los fármacos , Fluidoterapia , Soluciones Isotónicas/uso terapéutico , Oxígeno/sangre , Choque Hemorrágico/terapia , Animales , Perros , Hemodinámica , Hemorragia/sangre , Hemorragia/fisiopatología , Hipotensión/sangre , Hipotensión/fisiopatología , Soluciones Isotónicas/farmacología , Estudios Prospectivos , Intercambio Gaseoso Pulmonar , Distribución Aleatoria , Choque Hemorrágico/sangre , Choque Hemorrágico/fisiopatología
5.
Clin Chem ; 39(10): 2104-7, 1993 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8403394

RESUMEN

Our goal was to recreate a passive hemagglutination inhibition (PHAI) test to diagnose brown recluse spider (BRS; Loxosceles reclusa) bite envenomation for treatment trials. Guinea pigs received intradermal injections of concentrated spider venom from the following species: Loxosceles reclusa, Argiope aurantia, Argiope trifasciata, Phidippus audax, and Lycosa frondicola. Skin lesion exudate was collected and tested with the BRS venom PHAI assay. From 51 separate collections of exudate, test sensitivity was 90% as long as 3 days after venom injection. Specificity was 100% with venom from the other spider species listed above in vivo (7 test samples) and in vitro (5 test samples), as well as with random bacterial exudate with and without added serial dilutions of BRS venom (10 test samples). The test was reproducible over repetitive assays to within one 10-fold dilution. A positive PHAI test result could function as an entry criterion for BRS bite victims in human treatment trials.


Asunto(s)
Pruebas de Inhibición de Hemaglutinación/métodos , Picaduras de Arañas/diagnóstico , Venenos de Araña/análisis , Animales , Exudados y Transudados/química , Cobayas , Pruebas de Inhibición de Hemaglutinación/estadística & datos numéricos , Humanos , Sensibilidad y Especificidad , Enfermedades de la Piel/inducido químicamente , Venenos de Araña/toxicidad
6.
Ann Emerg Med ; 19(5): 568-71, 1990 May.
Artículo en Inglés | MEDLINE | ID: mdl-2331104

RESUMEN

Necrotizing fasciitis is a severe soft-tissue infection characterized by diffuse necrosis of fascia and subcutaneous tissue; initially, skin and muscle are usually spared. The trunk, abdomen, perineum, and extremities are the most commonly involved areas. The case of a 55-year-old man with a cervical necrotizing fasciitis from an infected tooth is presented. The medical history, etiology, anatomy, precipitating factors, clinical presentation, and therapy of this infection are discussed. Early recognition allows effective therapy with aggressive surgical intervention, broad-spectrum antibiotics, and supportive care. Misdiagnosis (eg, as cellulitis) and delayed surgical treatment can result in severe systemic toxicity and a mortality rate that approaches 40%.


Asunto(s)
Fascitis/cirugía , Enfermedades Dentales/cirugía , Antibacterianos/uso terapéutico , Fascitis/tratamiento farmacológico , Fascitis/etiología , Fascitis/microbiología , Humanos , Masculino , Persona de Mediana Edad , Cuello , Necrosis , Cuidados Posoperatorios , Enfermedades Dentales/complicaciones
7.
Ann Emerg Med ; 14(6): 540-6, 1985 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-3994077

RESUMEN

Our study examined the efficacy of four treatment modalities in controlling hemorrhage and achieving hemodynamic stabilization in hemorrhagic shock: intravenous fluid replacement (IV); military antishock trousers used concomitantly with fluids (MAST); balloon occlusion at the level of the diaphragm with concomitant fluid replacement (balloon); and a combination of MAST inflation, balloon occlusion, and fluid resuscitation (MAST and balloon). Twenty-eight mongrel dogs were anesthetized, and the spleen was exposed and completely crushed. The abdomen was closed, and treatment was initiated and continued for four hours or until the dog died. For all conditions the hematocrit dropped during the course of the experiment; balloon occlusion was effective at slowing this drop (P less than .0001), but MAST had no statistically significant effect. Animals with balloons bled more slowly into the abdominal cavity than did animals in the other two groups (P less than .0001). MAST also were effective at slowing the bleeding (P less than .05). Of the balloon and the MAST and balloon dogs, all except one survived the entire four hours; this difference between balloon and nonballoon dogs is significant (P = .002). MAST did not have a statistically significant effect on survival. Perfusion pressure (PP) declined during the course of the experiment, and the balloon was effective at slowing this decline (P less than .0001); none of the other comparisons was statistically significant.


Asunto(s)
Fluidoterapia , Trajes Gravitatorios , Resucitación/métodos , Choque Hemorrágico/terapia , Análisis de Varianza , Animales , Presión Sanguínea , Temperatura Corporal , Perros , Estudios de Evaluación como Asunto , Frecuencia Cardíaca , Presión , Factores de Tiempo , Heridas y Lesiones/terapia
8.
Ann Emerg Med ; 14(6): 591-3, 1985 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-3994086

RESUMEN

We present the case of a 27-year-old woman with a history of drug abuse. Following her routine intravenous (IV) injection of solubilized pentazocine and tripelennamine tablets ("Ts and Blues"), the patient developed severe hypertension, a finding not characteristic of either drug alone or of the combination. The manufacturers of Talwin (pentazocine) recently have added naloxone to the tablets to discourage IV abuse of this oral preparation. Our patient unknowingly had injected the new pentazocine formulation, and she subsequently developed narcotic withdrawal symptoms. Her hypertension was treated, and she was discharged from the emergency department. We report the case as an "unusual reaction" that may develop in frequent abusers of pentazocine and its combinations.


Asunto(s)
Hipertensión/inducido químicamente , Pentazocina , Trastornos Relacionados con Sustancias , Tripelenamina , Adulto , Clonidina/uso terapéutico , Femenino , Humanos , Hipertensión/tratamiento farmacológico , Inyecciones Intravenosas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...